Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCF inactivating Mutations in T Cell Acute Lymphoblastic Leukemia

MLA

Carlo Vermeulen, et al. “Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCF Inactivating Mutations in T Cell Acute Lymphoblastic Leukemia.” Blood, vol. 138, Nov. 2021, p. 501. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........15fba8fe28ecbbd16bb396925886e260&authtype=sso&custid=ns315887.

APA

Carlo Vermeulen, Eric Vroegindeweij, Jessica G.C.A.M. Buijs-Gladdines, Ellen van de Geer, Max van Min, Charles G. Mullighan, Willem K. Smits, Niels Galjart, Marjon J.A.M. Verstegen, Roland P. Kuiper, Arjan Buijs, Jules P.P. Meijerink, Rico Hagelaar, Shunsuke Kimura, Winfried Van Eyndhoven, Patrick Kemmeren, Simon V. van Reijmersdal, Wouter de Laat, & Erik Splinter. (2021). Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCF inactivating Mutations in T Cell Acute Lymphoblastic Leukemia. Blood, 138, 501.

Chicago

Carlo Vermeulen, Eric Vroegindeweij, Jessica G.C.A.M. Buijs-Gladdines, Ellen van de Geer, Max van Min, Charles G. Mullighan, Willem K. Smits, et al. 2021. “Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCF Inactivating Mutations in T Cell Acute Lymphoblastic Leukemia.” Blood 138 (November): 501. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........15fba8fe28ecbbd16bb396925886e260&authtype=sso&custid=ns315887.